Format

Send to

Choose Destination
Cell Death Differ. 2017 Jan;24(1):8-14. doi: 10.1038/cdd.2016.117. Epub 2016 Oct 21.

p53 on the crossroad between regeneration and cancer.

Author information

1
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Abstract

Regeneration and tumorigenesis share common molecular pathways, nevertheless the outcome of regeneration is life, whereas tumorigenesis leads to death. Although the process of regeneration is strictly controlled, malignant transformation is unrestrained. In this review, we discuss the involvement of TP53, the major tumor-suppressor gene, in the regeneration process. We point to the role of p53 as coordinator assuring that regeneration will not shift to carcinogenesis. The fluctuation in p53 activity during the regeneration process permits a tight control. On one hand, its inhibition at the initial stages allows massive proliferation, on the other its induction at advanced steps of regeneration is essential for preservation of robustness and fidelity of the regeneration process. A better understanding of the role of p53 in regulation of regeneration may open new opportunities for implementation of TP53-based therapies, currently available for cancer patients, in regenerative medicine.

PMID:
27768121
PMCID:
PMC5260496
DOI:
10.1038/cdd.2016.117
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center